All Type of News
Listed pharmas taking steps back in R&D investment
Listed pharmaceutical companies were criticized that they took a step back in R&D investment.
Yakup Shinmoon(www.yakup.com) analyzed KOSPI and KOSDAQ listed pharmaceutical companies’ 2017 3rd quarter business perform...
Disposal of CJ HealthCare, who will purchase its value and potential?
After the CJ HealthCare’s announcement of disposal, no one has made a move yet, which created various talks.
Key points that the industry have mentioned are if the company will be well disposed as the CJ HealthCare o...
Long- & fact-acting insulins into a single pen? Ryzodeg on release
‘Ryzodeg(generic name: insulin degludec 70U.mL, insulin aspart 30U/mL),’ the first and only combined insulin with super-long-acting insulin and fast-acting insulin into a single pen, emerged.
Most of all, by combinin...
Government’s support plans from novel drug development using AI to tax benefits
The government’s widely ranged plans to support the pharmaceutical industry has started to be visualized from R&D(smart clinical study platforms and artificial intelligence for novel drug development), trainings for t...
Listed pharmas’ decent external business growth
Listed pharmaceutical companies were evaluated having a decent business performance this year, but sales gaps between the companies were intensified.
1 of 3 listed pharmaceutical companies had a decrease in operating...
Listed pharmas’ decent external business growth
Listed pharmaceutical companies were evaluated having a decent business performance this year, but sales gaps between the companies were intensified.
1 of 3 listed pharmaceutical companies had a decrease in operating...
Korea follows only 71.4% of U.S. drug development technology
It was analyzed the Korea’s technological level of drug development was 71.4% of what the U.S. had and the technological gap was 4.1 years.
The Ministry of Health and Welfare and the Korea Health Industry Development...
Ilyang Pharmaceutical’s ‘Supect’ effectively inhibits Parkinson’s disease progress
The preclinical and efficacy result on the Ilyang Pharmaceutical’s(President Dong-Yeon Kim) chronic myelocytic leukemia treatment ‘Supect(generic name: radotinib)’ for Parkinson’s disease(PD) was announced at the ‘Ame...
Only did 1 of 10 seniors have experience in hearing about generic substitution from pharmacists
Since it was only 1 of 10 seniors who were guided generic substitution, it was reported it needed to strengthen the consumers’ right to choose medicines.
According to the ‘Senior Consumer Right Strengthening Plan(Med...
Korea’s health care quality improved, but use of quinolone antibiotics is higher than OECD average
The Korean health care quality including outpatient prescription has been reportedly enhanced overall, but the management of chronic diseases was diagnosed that it needed improvements.
The Organisation for Economic C...
